上海貝嶺(600171.SH):上半年公司新增20餘顆產品上車應用
格隆匯12月5日丨有投資者向上海貝嶺(600171.SH)提問:公司汽車芯片在研芯片推廣進度如何?今年下半年和明年,都有哪些汽車芯片開始供貨?
上海貝嶺回覆:2023年上半年,公司新增20餘顆產品上車應用,汽車電子業務銷售收入同比增長約40%。其中,LED驅動產品和點火IGBT產品技術與批量運行經驗處於國內領先地位,通用電源、EEPROM存儲器、功率器件等多款產品進入頭部車廠和Tier1。公司已有和在研的汽車電子產品覆蓋發動機控制單元、汽車主驅、車燈、汽車電池管理系統、車載充電機、汽車熱管理系統、汽車座椅、車機、車門窗、汽車充電樁等應用領域。謝謝!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.